Dermscan is headquartred in Lyon, France, and present today in Tunisia (Tunis), Poland (Gdansk), Thailand (Bangkok) and Mauritius (Quatre Bornes).
The company has an established reputation for safety, efficacy and in-vitro testing and clinical studies, serving industries in Europe, Asia and Africa.
“Eurofins welcomes the unmatched expertise in cosmetic testing from Dermscan in a market where the expectancy for safety and efficacy is among the highest in the world,” says the worldwide laboratory testing company of its new acquisition.
“We are confident that this acquisition will contribute to the expansion of footprint and strengthening of our expertise in the cosmetics testing industry by offering an increasingly wider scope of top-class services and facilitating the development of innovative new solutions for our customers,” asserts Stéphane Barrau, Vice President of Eurofins Consumer Product Testing.
Global ambitions for Eurofins
The acquisition forms part of Eurofins strategy, according to the company, to expand its global testing footprint in cosmetics.
As of this latest acquisition, the company boasts 40 laboratories active across Europe, North America, Asia, Australia and Africa.
“This is a new adventure and a new challenge for the entire Dermscan’s team that we are very excited to undertake. Joining Eurofins will enable us to propose an even more complete and diversified offer to the cosmetics industry,” says Frédérique Girard-Ory, General Manager of Dermscan.
